Kuros Biosciences AG (SWX:KURN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
21.64
+1.34 (6.60%)
Oct 26, 2026, 1:20 PM CET

Kuros Biosciences AG Revenue

Kuros Biosciences AG had revenue of $92.35M USD in the half year ending June 30, 2026, with 158.81% growth. This brings the company's total for the last twelve months to $174.93M, up 54.87% year-over-year. In the year 2025, Kuros Biosciences AG had annual revenue of $146.06M with 71.51% growth. That makes Kuros Biosciences AG the 18,606th largest company in the world by revenue and 158th in Switzerland.

Revenue (ttm)
$174.93M
Revenue Growth
+54.87%
P/S Ratio
5.71
Revenue / Employee
$821.28K
Employees
213
Market Cap
860.33M CHF

Revenue Chart

* This company reports financials in USD.

Revenue by Geography

  • United States of America 140.94M 96.5%
  • European Union 3.11M 2.1%
  • Other 2.01M 1.4%
Fiscal year ended Dec 31, 2025 See the full Kuros Biosciences AG breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025146.06M60.90M71.51%
Dec 31, 202485.16M45.25M113.38%
Dec 31, 202339.91M20.46M105.15%
Dec 31, 202219.45M4.30M28.39%
Dec 31, 202115.15M10.66M237.01%
Dec 31, 20204.50M1.85M69.84%
Dec 31, 20192.65M1.92M264.23%
Dec 31, 2018726.81K178.92K32.66%
Dec 31, 2017547.90K-494.55K-47.44%
Dec 31, 20161.04M898.38K623.61%
Dec 31, 2015144.06K-862.63K-85.69%
Dec 31, 20141.01M-114.00K-10.17%
Dec 31, 20131.12M-81.17K-6.75%
Dec 31, 20121.20M-470.53K-28.14%
Dec 31, 20111.67M-22.24M-93.01%
Dec 31, 201023.91M20.60M622.19%
Dec 31, 20053.31M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.